FLGT - Fulgent Genetics, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 1.18B
Enterprise value 696.75M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.33
Price/book (mrq)0.93
Enterprise value/revenue 1.91
Enterprise value/EBITDA -66.94

Trading information

Stock price history

Beta (5Y monthly) 1.55
52-week change 3-24.36%
S&P500 52-week change 34.08%
52-week high 365.17
52-week low 328.27
50-day moving average 333.44
200-day moving average 335.23

Share statistics

Avg vol (3-month) 3234.41k
Avg vol (10-day) 3281.11k
Shares outstanding 529.7M
Implied shares outstanding 6N/A
Float 820.06M
% held by insiders 131.80%
% held by institutions 145.33%
Shares short (14 May 2023) 4809.48k
Short ratio (14 May 2023) 44.21
Short % of float (14 May 2023) 44.83%
Short % of shares outstanding (14 May 2023) 42.73%
Shares short (prior month 13 Apr 2023) 4745.84k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin -7.10%
Operating margin (ttm)-9.85%

Management effectiveness

Return on assets (ttm)-1.58%
Return on equity (ttm)-2.13%

Income statement

Revenue (ttm)364.87M
Revenue per share (ttm)12.19
Quarterly revenue growth (yoy)-79.30%
Gross profit (ttm)366.9M
Net income avi to common (ttm)-25.92M
Diluted EPS (ttm)-0.83
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)504.48M
Total cash per share (mrq)16.99
Total debt (mrq)35.33M
Total debt/equity (mrq)2.78
Current ratio (mrq)7.09
Book value per share (mrq)42.58

Cash flow statement

Operating cash flow (ttm)57.2M
Levered free cash flow (ttm)72.18M